CRTAM Antibodies

Santa Cruz Biotechnology features a diverse variety of CRTAM monoclonal antibodies for various research applications. CRTAM monoclonal antibodies enable precise detection in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytotoxic T lymphocyte-associated protein 4 (CRTAM) plays a crucial role in the immune response by regulating T cell activation and promoting the cytotoxic activity of T cells against tumor cells. CRTAM's importance in cancer immunotherapy and potential as a therapeutic target makes it a significant focus of research in the field of immunology. Understanding CRTAM function can provide insights into immune evasion mechanisms employed by tumors and help in the development of novel treatment strategies. Researchers worldwide utilize CRTAM monoclonal antibodies to explore immune system regulation and T cell responses. Current investigations focus on CRTAM's role in tumor surveillance and potential applications in immunotherapy development. CRTAM monoclonal antibodies from Santa Cruz Biotechnology support researchers in advancing scientific understanding of immune system regulation and cancer biology.